Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06298929
Other study ID # 36264PR427/11/23
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date November 15, 2023
Est. completion date October 15, 2024

Study information

Verified date March 2024
Source Mansoura University
Contact Ameera G Abdelhameed, MD
Phone +201120090000
Email amiragamal287@mans.edu.eg
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This prospective comparative study aims to compare medial rectus (MR) muscle fenestration and recession in patients with partially accommodative esotropia (PAET). The main question it aims to answer is whether MR fenestration is equally effective as MR recession for PAET. All patients will receive complete ophthalmic and orthoptic assessment. Patients will be randomly allocated using a random table to one of two groups; Group 1 will receive conventional MR recession, and Group 2 will receive MR fenestration.


Description:

Inclusion criteria The study will include patients with accommodative esotropia if the residual distance deviation with full cycloplegic correction is > 15PD. Exclusion criteria: 1. Patients with convergence excess esotropia, defined as a near deviation with glasses exceeding that for distance by 15 PD or more. 2. Patients with paralytic or restrictive strabismus. 3. Patients with previous strabismus surgery 4. Patients with neurologic, ocular, or developmental disorders or follow-up less than 6 months All patients will receive complete ophthalmic and orthoptic assessment including: i) A full ophthalmological assessment including history taking, measurement of uncorrected and best-corrected visual acuity, cycloplegic refraction, anterior segment examination, as well as a dilated fundus examination. ii) Measurement of the deviation at distance (6 m) and near (33 cm). iii) Assessment of ductions and versions in all cardinal directions of gaze Patients will be randomly allocated using a random table to one of two groups: 1. Group 1: Unilateral or bilateral conventional MR recession. Augmented formula will be used to decide the Surgical dosage using the standard tables (3) 2. Group 2: unilateral or bilateral MR fenestration All surgeries will be performed by one experienced surgeon (H.SH)


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date October 15, 2024
Est. primary completion date September 15, 2024
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - patients with accommodative esotropia if the residual distance deviation with full cycloplegic correction is > 15PD. Exclusion Criteria: 1. convergence excess esotropia. 2. paralytic or restrictive strabismus. 3. previous strabismus surgery 4. neurologic, ocular, or developmental disorders or follow-up less than 6 months

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
medial rectus fenestration
Fenestration technique involves making two splitting incisions by blunt dissection parallel to the muscle fibers on the superior and inferior borders of the muscle, leaving 1 mm of muscle fibers on each edge. The rectangular wide central part is excised from the insertion and between the two splitting incisions to a point back 5-8 mm depending on the angle of the esotropia.
medial rectus recession
recession is one of the gold standard weakening procedures that involves disinsertion of the muscle and re-suturing to the sclera at a more posterior location to decrease its contractile power.

Locations

Country Name City State
Egypt Tanta University Tanta Gharbeya

Sponsors (2)

Lead Sponsor Collaborator
Mansoura University Tanta University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Ocular alignment (measured in prism diopters) The distance and near angles of deviation, with and without glasses, and the angle disparity 6 months postoperative
Secondary ocular motility ductions of both eyes (graded on a scale of nine points from -4 to +4) 6 months postoperative
See also
  Status Clinical Trial Phase
Completed NCT02413463 - Augmented Medial Rectus Muscle Recession Versus Posterior Scleral Fixation in Partially Accommodative Esotropia N/A